Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
Chubb
Julphar
Cipla
Federal Trade Commission
Farmers Insurance
Chinese Patent Office
Teva

Generated: October 21, 2017

DrugPatentWatch Database Preview

Procyclidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for procyclidine hydrochloride and what is the scope of procyclidine hydrochloride patent protection?

Procyclidine hydrochloride
is the generic ingredient in one branded drug marketed by Monarch Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for procyclidine hydrochloride.

Summary for Generic Name: procyclidine hydrochloride

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Bulk Api Vendors: see list20
Clinical Trials: see list2,287
Patent Applications: see list274
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:procyclidine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms
KEMADRIN
procyclidine hydrochloride
TABLET;ORAL009818-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Monarch Pharms
KEMADRIN
procyclidine hydrochloride
TABLET;ORAL009818-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
McKesson
AstraZeneca
Mallinckrodt
Chubb
Argus Health
Dow
Medtronic
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot